UC WAR. CALL 12/24 NESR/ DE000HD7TP31 /
2024-09-04 9:45:25 PM | Chg.-0.0800 | Bid9:59:32 PM | Ask9:59:32 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.4600EUR | -14.81% | 0.4100 Bid Size: 8,000 |
0.5200 Ask Size: 8,000 |
NESTLE N | 88.00 CHF | 2024-12-18 | Call |
GlobeNewswire
08-13
Seres Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
08-06
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
GlobeNewswire
07-23
Mondelēz International Names Filippo Catalano Chief Information and Digital Officer
GlobeNewswire
06-12
NFWF Announces $10.2 Million in Grants to Cultivate Conservation Practices on Agricultural Lands
GlobeNewswire
06-06
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Sc...
GlobeNewswire
05-08
WalkMe Announces Date of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
03-26
NESTLE INTERNATIONAL AWARDED OMNIQ A PURCHASE ORDER FOR THE SUPPLY OF RUGGEDIZED IOT EQUIPMENT TO NE...
GlobeNewswire
03-19
VML Augments Digital Commerce Capabilities by Forging Partnership with CommerceIQ’s Unified Artifici...